CompletedNCT00056277
Lamotrigine for mood symptoms in bipolarity
Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Beverly Hills and 19 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateFebruary 27, 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 150
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00056277
- Official title
Show the full official title
Double Blind Placebo Controlled Study of Lamictal in Acute Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Beverly Hills · La Jolla · San Diego
17 more locations
- Santa Ana
- Marietta
- Terre Haute
- Shreveport
- Saint Charles
- Princeton
- New York
- Pleasantville
- Raleigh
- Brecksville
- Cincinnati
- Cleveland
- Eugene
- Portland
- Columbia
- San Antonio
- Brown Deer
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is GlaxoSmithKline.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine.
Who was this study for?
Listed age limits: from 18 years.
